In contrast to non-Hodgkin's lymphoma, BCL2 protein expression in breast cancer is associated with an indolent phenotype of low-grade, slowly proliferating, ER+ breast tumours (Silvestrini et al, 1994; Lipponen et al, 1995). Here, BCL2 is linked to breast neoplasm.